Latest Form 4 insider transactions

NYSE
Bindley Capital Partners I, LLC reported changes in beneficial ownership of Guardian Pharmacy Services, Inc. common stock on September 27, 2026.
NASDAQ
Nathaniel Lipman, a Director of Dave & Buster's Entertainment, Inc., received 10,572 shares of common stock on September 25, 2026.
OQX
Kimberly K Chuckalovchak, SVP, Chief Information Officer of Consumers Bancorp Inc /Oh/, reported multiple transactions in common stock on September 28, 2026.
NASDAQ
Robert I Blum, President & CEO and a Director of Cytokinetics Inc, sold 7,500 shares of common stock on September 28, 2026 for $65.46 per share.
NYSE
Douglas Towns, See Remarks of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.
OQX
David R Bickerton, a Director of Consumers Bancorp Inc /Oh/, reported multiple transactions in common stock on September 28, 2026.
NASDAQ
Charles Protell, a Director of Dave & Buster's Entertainment, Inc., received 10,572 shares of common stock on September 25, 2026.
OQX
Ralph J Lober Ii, CEO & President and a Director of Consumers Bancorp Inc /Oh/, reported multiple transactions in common stock on September 28, 2026.
NASDAQ
Daniel James Drobac, VP & Chief Accounting Officer of T-Mobile US, Inc., received 2,768 shares of common stock on September 24, 2026.
OQX
Renee Wood, EVP & Chief Financial Officer of Consumers Bancorp Inc /Oh/, reported multiple transactions in common stock on September 28, 2026.
NASDAQ
Mani Sundaram, EVP and GM Security of Akamai Technologies Inc, sold 7,022 shares of common stock on September 25, 2026 for $125.62 per share.
NASDAQ
Rachel Morgan, Chief Legal Officer, Corp Sec of Dave & Buster's Entertainment, Inc., reported multiple transactions in common stock on September 25, 2026.
NYSE
Medtronic plc is offering to exchange newly issued shares of MiniMed Group, Inc. for its own common stock, a move aimed at restructuring its holdings.
OQX
Derek G Williams, SVP, Retail Operations & Sales of Consumers Bancorp Inc /Oh/, reported multiple transactions in common stock on September 28, 2026.
NASDAQ
Paul J Tufano, a Director of Teradyne, Inc, reported multiple transactions in common stock on September 24, 2026.
OQX
Suzanne N Mikes, EVP, Chief Credit Officer of Consumers Bancorp Inc /Oh/, reported multiple transactions in common stock on September 28, 2026.
NASDAQ
William O'Dowd Iv, Chief Executive Officer, a Director and 10% owner of Dolphin Entertainment, Inc., purchased 4,400 shares of common stock on September 28, 2026 for $1.11 per share.
NASDAQ
Ernest E Maddock, a Director of Teradyne, Inc, reported a transaction in 2 shares of common stock on September 25, 2026.
NYSE
John F Mcgarry, a Director of Aegon Ltd., received 61 shares of common stock on September 24, 2026.
NYSE
Jay Stuart Ralph, a Director of Aegon Ltd., received 61 shares of common stock on September 24, 2026.
NASDAQ
Kim Salem-Jackson, EVP, Chief Marketing Officer of Akamai Technologies Inc, sold 2,013 shares of common stock on September 25, 2026 for $128.00 per share.
NASDAQ
Andrew Chisholm Henry, a Director of Teradyne, Inc, received 64 shares of common stock on September 24, 2026.
OTC.Pink
Corey Allen Lambrecht, President, COO and a Director of American Rebel Holdings Inc, reported a transaction in 10,000 shares of common stock on September 22, 2026.
NASDAQ
Louis Todd Borgmann, CHIEF EXECUTIVE OFFICER of Calumet, Inc. /DE, reported multiple transactions in common stock on September 25, 2026.
NYSE
Susan E Sweeney, See Remarks of Tredegar Corp, received 8,343 shares of common stock on September 25, 2026.
NASDAQ
Bruce A Fleming, EVP - MONTANA RENEWABLES of Calumet, Inc. /DE, reported multiple transactions in common stock on September 25, 2026.
NASDAQ
Gregory J Morical, SVP, GENERAL COUNSEL of Calumet, Inc. /DE, reported multiple transactions in common stock on September 25, 2026.
NYSE
Richard A Maue, a Director of Federal Signal Corp /De/, received 108 shares of common stock on September 25, 2026.
OQB
Gregory R. Alexander, CEO of Syra Health Corp, received 368,458 shares of common stock on August 11, 2026.
OQB
Gregory R. Alexander, CEO of Syra Health Corp, reported multiple transactions in common stock on January 5, 2026.